SCHEMBL29317136

SCHEMBL29317136

Cc1ncc(Br)cc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16781667 0.77
SCHEMBL1180586 0.75
SCHEMBL12287341 0.75
SCHEMBL29845509 0.75
SCHEMBL19936157 0.75
SCHEMBL24404928 0.75
SCHEMBL663225 0.75
SCHEMBL29393124 0.75
SCHEMBL3585029 0.73
SCHEMBL584147 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240391900-A1 RIP1 KINASE INHIBITOR AND USE THEREOF SIRONAX (BEIJING) CO., LTD. (CN) 2024-11-28 US disclosed
EP-4400497-A1 3CLPRO PROTEASE INHIBITOR Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) 2024-07-17 EP disclosed
CN-117957230-A RIP1 kinase inhibitors and uses thereof 维泰瑞隆(北京)生物科技有限公司 2024-04-30 CN disclosed
WO-2023040870-A1 RIP1 KINASE INHIBITOR AND USE THEREOF 维泰瑞隆(北京)生物科技有限公司 2023-03-23 WO disclosed
WO-2023039795-A1 RIP1 KINASE INHIBITOR AND USE THEREOF 维泰瑞隆(北京)生物科技有限公司 2023-03-23 WO disclosed